Humacyte Inc.
HUMA | NASDAQ
$0.59
$0 (0.00%)
Sep 22, 2026, 2:11 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.04M | n/a | n/a | 1.57M | 1.26M | 1.49M |
Cost of Revenue | 17.05M | 7.19M | 76.55M | 8.26M | 61.34M | 54.08M |
Gross Profit | -15.01M | -7.19M | -76.55M | -6.69M | -60.08M | -52.59M |
Operating Income | -107.44M | -114.4M | -100.05M | -84.58M | -81.21M | -64.6M |
Interest Income | 2.59M | 4.1M | 5.47M | 2.63M | 16K | 278K |
Pretax Income | -40.83M | -148.7M | -110.78M | -11.97M | -26.48M | -66.52M |
Net Income | -40.83M | -148.7M | -110.78M | -11.97M | -26.48M | -66.52M |
Selling & General & Admin | 31.17M | 25.8M | 20.39M | 22.88M | 21.13M | 12.01M |
Research & Development | 69.3M | 88.6M | 76.55M | 63.26M | 61.34M | 54.08M |
Other Expenses | -8.05M | -7.19M | -73.44M | -8.26M | -61.34M | -54.08M |
Operating Expenses | 92.43M | 107.21M | 23.5M | 77.89M | 21.13M | 12.01M |
Interest Expense | 11.25M | 9.28M | 6.6M | 6.2M | 4.35M | 2.2M |
Selling & Marketing Expenses | n/a | n/a | -3M | n/a | 105K | 152K |
Cost & Expenses | 109.48M | 114.4M | 100.05M | 86.14M | 82.47M | 66.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 158.16M | 118.48M | 103.42M | 103.05M | 39.97M | 12.45M |
Shares Outstanding (Diluted) | 158.16M | 118.48M | 103.42M | 103.05M | 39.97M | 12.45M |
EPS (Basic) | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 | -5.52 |
EPS (Diluted) | -0.26 | -1.26 | -1.07 | -0.12 | -0.66 | -5.52 |
EBITDA | -22.24M | -132.23M | -96.46M | 2.45M | -13.89M | -56.25M |
EBIT | -29.58M | -139.42M | -104.18M | -5.77M | -22.13M | -64.6M |
Depreciation & Amortization | 7.35M | 7.19M | 7.72M | 8.21M | 8.24M | 8.35M |
Add to Watchlist
Select watchlists to add or remove HUMA